Arcadia Biosciences (nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity.[2][3] The company is partly owned by Moral Compass Corporation.[4]
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat.[5][6][7] Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017.[8][9] HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.[10]
External links
References
- US SEC: Form 10-K Arcadia Biosciences United States Securities and Exchange Commission, retrieved May 9, 2018^
- "Arcadia Biosciences: Company overview" Retrieved on 9 May 2018.^
- Michael Taylor. Arcadia Biosciences (RKDA) vs. The Competition Head to Head Review 4 May 2018, retrieved 10 May 2018^
- Arcadia Biosciences, Inc. (RKDA) and United States Steel Corp. (X) Activist Update - ValueWalk 10 March 2018, retrieved 10 May 2018^
- Mark Anderson. Arcadia announces reduced-gluten wheat for breads, pasta Sacramento Business Journal, April 17, 2018^
- Mark Anderson. Arcadia Biosciences' GoodWheat product could be on supermarket shelves this year Sacramento Business Journal, March 21, 2018^
- Mark Anderson. Davis-based Arcadia Biosciences crosses the valley of death Sacramento Business Journal, April 6, 2018, retrieved 10 May 2018^
- Drought Tolerant HB4 Soybeans Introduced in Argentina- Crop Biotech Update www.isaaa.org, retrieved 2018-08-21^
- IND-ØØ41Ø-5 www.isaaa.org, retrieved 2018-08-21^
- Bioceres drought tolerant soybean ready to market in 2019 Farm News Argentine, 2018-06-27, retrieved 2018-08-21^